Cargando…

Mechanism of action of Tripterygium wilfordii for treatment of idiopathic membranous nephropathy based on network pharmacology

BACKGROUND: Although thunder god vine (Tripterygium wilfordii) has been widely used for treatment of idiopathic membranous nephropathy (IMN), the pharmacological mechanisms underlying its effects are still unclear. This study investigated potential therapeutic targets and the pharmacological mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Honghong, Hou, Yanjuan, Su, Xiaole, Qiao, Jun, Wang, Qian, Guo, Xiaojiao, Gao, Zhihong, Wang, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856020/ https://www.ncbi.nlm.nih.gov/pubmed/35172688 http://dx.doi.org/10.1080/0886022X.2021.2024850

Ejemplares similares

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study
por: Liu, Shanshan, et al.
Publicado: (2015)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
por: Wang, Hongyun, et al.
Publicado: (2023)

Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy
por: Xia, Ming, et al.
Publicado: (2021)

Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022)

Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021)

Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis
por: Jin, Yuxia, et al.
Publicado: (2020)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
por: Wang, Lin, et al.
Publicado: (2021)

Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy
por: HAO, LI, et al.
Publicado: (2014)

Exploring the pharmacological mechanism of Tripterygium wilfordii hook for treatment of Behcet’s disease using network pharmacology and molecular docking
por: Ye, Lihua, et al.
Publicado: (2023)

Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial
por: Ge, Yongchun, et al.
Publicado: (2013)

Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii
por: Tu, Lichan, et al.
Publicado: (2022)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021)

Molecular mechanism of reproductive toxicity induced by Tripterygium Wilfordii based on network pharmacology
por: Ding, Qing, et al.
Publicado: (2021)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
por: Liu, Peng, et al.
Publicado: (2021)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Exploration of the Mechanism of Tripterygium Wilfordii in the Treatment of Myocardial Fibrosis Based on Network Pharmacology and Molecular Docking
por: Ming, Yang, et al.
Publicado: (2023)

The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway
por: Pei, Tianlin, et al.
Publicado: (2021)

Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (Lév.) Hutch Against IgA Nephropathy
por: Zhao, Juanyong, et al.
Publicado: (2023)

Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii
por: Zhao, Yu-Jun, et al.
Publicado: (2015)

Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia
por: Fang, Tingting, et al.
Publicado: (2020)

Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking
por: Huang, Bingwu, et al.
Publicado: (2021)

Network Pharmacology and Molecular Docking Analysis Exploring the Mechanism of Tripterygium wilfordii in the Treatment of Oral Lichen Planus
por: Huang, Wenkai, et al.
Publicado: (2023)

Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking
por: Lu, Meiqi, et al.
Publicado: (2023)

Investigating the Catalytic Activity of Glycosyltransferase on Quercetin from Tripterygium wilfordii
por: Gao, Jie, et al.
Publicado: (2020)

The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
por: Zhong, Yuan, et al.
Publicado: (2022)

Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial
por: Lengnan, Xu, et al.
Publicado: (2020)

Immunosuppressive Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f.
por: Wang, Yadan, et al.
Publicado: (2022)

Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
por: Tong, Xue, et al.
Publicado: (2022)

The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
por: Chen, Yixuan, et al.
Publicado: (2022)

Native Endophytes of Tripterygium wilfordii-Mediated Biotransformation Reduces Toxicity of Celastrol
por: Ma, Ping-yang, et al.
Publicado: (2022)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Comparative analysis of four terpenoids in root and cortex of Tripterygium wilfordii Radix by different drying methods
por: Wang, Tuanjie, et al.
Publicado: (2016)

Genome of Tripterygium wilfordii and identification of cytochrome P450 involved in triptolide biosynthesis
por: Tu, Lichan, et al.
Publicado: (2020)

Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii
por: Ji, Wei, et al.
Publicado: (2010)

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii
por: Ni, Lin, et al.
Publicado: (2018)

Molecular Cloning and Characterization of DXS and DXR Genes in the Terpenoid Biosynthetic Pathway of Tripterygium wilfordii
por: Tong, Yuru, et al.
Publicado: (2015)

A Network Pharmacology Study on the Active Ingredients and Potential Targets of Tripterygium wilfordii Hook for Treatment of Rheumatoid Arthritis
por: Hu, Wei, et al.
Publicado: (2019)

A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease
por: Wang, Yuyang, et al.
Publicado: (2020)

Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis
por: Li, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sndbnm5iutb3n45lnblbra4fu7